But we will make a critical error if we ignore the need for treatments as well as vaccines. So, it is vitally important we continue to research treatments to limit and cure COVID-19. President Biden should also organize an advisory panel to coordinate these clinical trial efforts and share results from outcomes and best practices. Because it is in the interest of national security, such coordination and prioritization of clinical trials cannot be left to the profit-driven pharmaceutical industry. We are making steady progress but must significantly enhance support for research and for national coordination of clinical trial efforts.